Product Description: ML261 is a hepatic lipid droplets formation inhibitor with an IC50 value of 69.7 nM. ML261 can be used for the research of non-alcoholic fatty liver disease (NAFLD) and inflammation[1].
Applications: COVID-19-immunoregulation
Formula: C20H23ClN2O3S
References: [1]Zou J, et al. Potent inhibitors of lipid droplet formation. 2014.
CAS Number: 902523-58-4
Molecular Weight: 406.93
Compound Purity: 99.80
Research Area: Inflammation/Immunology
Solubility: DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)